CorMedix Inc. CRMD, a pharmaceutical company focused on developing and commercializing
therapeutic products for the prevention and treatment of cardiac, renal and
infectious diseases, today announced that the extension to April 30, 2015 of
the expiration date applies to all publicly traded warrants.
The holders of CorMedix warrants should note that the Company issued two
tranches of warrants in 2010 with the same CUSIP number (No.21900C118). The
first tranche of warrants were purchased for cash in connection with the
Company's initial public offering of common stock in 2010, and may be
exercised at the specified exercise price in exchange for registered, freely
tradable shares of common stock issued pursuant to a currently effective
registration statement.
The second tranche of warrants was also issued in 2010 to a select group of
investors in exchange for debt issued prior to the Company's initial public
offering. The holders of these warrants may exercise and receive in exchange
shares of unregistered common stock. The Company intends to file a
registration statement for the resale of the shares issuable upon exercise of
the second tranche of warrants as soon as practicable following the filing
later this week of the Company's Annual Report Form 10-K.
The exercise date for both tranches of warrants, inclusive of all publicly
traded warrants, has been extended from March 24, 2015 to April 30, 2015.
Holders of CorMedix warrants should contact the Company's transfer agent,
VStock Transfer, LLC, at the number set forth below for assistance in
determining whether their respective warrants were issued in the first or
second tranche. Prior to the availability of the resale registration statement
described above, upon exercise holders will not receive shares of common stock
free from restrictions on trading unless they can establish that their
warrants were originally issued as part of the first tranche.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in